We have demonstrated exosomes from secreted TGF-β1 gene-modified dendritic cells (DCs) (sTGF-β1-EXO) delay the development of murine inflammatory bowel disease (IBD). This evidence concerns the gene TGFB1 and inflammatory bowel disease.